@FierceMedDev: Hamburg: FDA is a bargain for taxpayers. Story | Follow @FierceMedDev
@DamianFierce: LabCorp is slimming down and diversifying to stay profitable in a tough testing market. More | Follow @DamianFierce
> Medtronic ($MDT) is on the verge of laying off employees in its spinal division, Memphis Business Journal reports, but the company is so far mum on how many jobs it will cut. Article
> Intuitive Surgical ($ISRG) targeted surgeons with "basic or limited" skill sets while marketing its much-scrutinized da Vinci robots, a company executive testified. Story
> Diagnostics company Good Start Genetics is touting data showing its carrier screening platform can detect pathogenic mutations missed by conventional technologies. Release
> Consumers Union is urging the FDA to follow through on its plan to require PMA-quality safety data on all-metal hip implants already on the market. Item
> Johns Hopkins has partnered with DKBmed to launch an app designed to facilitate HIV screening. More
Biotech News
@FierceBiotech: Hear from top execs at Janssen talk about drug R&D, industry's drug pipeline efforts. More | Follow @FierceBiotech
@RyanMFierce: Biotech rattled as Q1 first-time VC deals plunge to 18-year low. News | Follow @RyanMFierce
> Pharma giants' oral EPO alternatives could cater to dopers. More
> Vertex skyrockets on positive Ph2 combo study in cystic fibrosis. Story
> Epizyme hits the biotech IPO queue with rapid R&D plan for cancer drugs. Report
Pharma News
@FiercePharma: U.K. likely to pay for Avastin despite another NICE rejection. More | Follow @FiercePharma
@EricPFierce: Some popular drugs like Pradaxa, Prolia to be put through despised German price shredding formula. Story | Follow @EricPFierce
> Russia tells Abbott no-go on buyout of partner Petrovax. Article
> U.K. goes after GSK for decade-old pay-for-delay deal. Story